Target intelligence / Profile preview

E3 ubiquitin-protein ligase ZNRF4 (ZNRF4)

Target
ZNRF4
Molecular classification
Enzyme, E3 ubiquitin ligase, RING finger protein, Zinc finger protein
01

Overview

E3 ubiquitin-protein ligase ZNRF4 (ZNRF4) is a member of the RING finger protein family characterized by a cysteine-rich zinc finger domain that coordinates two zinc ions, enabling its function as an E3 ligase in the ubiquitin-proteasome system[1][3][5]. ZNRF4 mediates the transfer of ubiquitin from E2 conjugating enzymes to specific substrate proteins, directing them for proteasomal degradation. It acts as a negative regulator of NOD2 signaling by ubiquitinating and promoting the degradation of RIPK2, which results in attenuation of innate immune responses[6]. ZNRF4 is implicated in immune tolerance and may contribute to the control of inflammation. No direct drug modulators or clinical biomarkers are currently established for ZNRF4, but alterations in its activity may influence immune-related disorders[6].

Other names
RNF204SperizinNixinSPZNSsrzf1RING finger protein 204RING-type E3 ubiquitin transferase ZNRF4Zinc/RING finger protein 4
02

Mechanism of action

Ubiquitin ligase activity mediating ubiquitination and proteasomal degradation of substrate proteins (e.g., RIPK2)

03

Biological functions

UbiquitinationNegative regulation of innate immune signaling (NOD2 pathway)Protein degradation (via ubiquitin-proteasome system)
04

Disease associations

InflammationImmune-related diseasesPotential role in infection response and immune tolerance
05

Safety considerations

Potential impact on immune homeostasis if inhibited or dysregulated

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase ZNRF4 (ZNRF4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase ZNRF4 (ZNRF4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call